This study resulted in the lead compound SHP2‐D26 (83), which promoted complete degradation of SHP2 in AML cells (MV4;11) with a concentration of 100 nM after 12 h, with a DC50 value of 2.6 nM.180. The gene discussed is PTPN11; the disease is acute myeloid leukemia.